Page 135 - Drug Class Review

Drug Effectiveness Review Project

Alzheimer Drugs Authors: Lanctot et al. 30 Year: 2003 Country: Canada NR; several authors have received speaker fees or honoraria from pharmaceutical companies; two authors are employed by pharmaceutical companies Study design: Meta analysis of placebo-controlled trials Number of patients: 7,954 To quantitatively summarize data on the efficacy and safety of ChE inhibitors in AD Rogers 1996; Rogers 1998a; Rogers 1998b; Burns 1999; Winblad 2001; Homma 2000; Mohs 2001; Feldman 2001; Agid 1998; Rösler 1999; Corey-Bloom 1998; Raskind 2000; Wilcock 2000; Tariot 2000; Rockwood 2001; Wi

Final Report Update 1 Efficacy/Effectiveness STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN META-ANALYSIS TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs